/PRNewswire/ Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced that Bruce Pritchard, Chief Executive Officer at.
LAVAL, QC and CAMBRIDGE, England, Jan. 19, 2023 /PRNewswire/ Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced that Bruce Pritchard, Chief Executive
/PRNewswire/ Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), announced that Bruce Pritchard, Chief Executive Officer at.
/PRNewswire/ Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), is pleased to provide an overview of the Company s priorities.
Closed December 2022 with just over CAD 37 million cash on hand, expecting to provide a runway into early 2024.Plans to divest its remaining non-core assets, to further extend runway.Nominated